Video Library & Webinars | Oncotype DX Test

Unlocking the Oncotype DX Breast Recurrence Score^® Test: Unique design and development to bring clarity to treatment decisions

Loading component...

ESMO Breast Cancer 2025

Key Messages from the Exact Sciences Symposium

Professor Marc A. Thill: Welcome and Introduction

Professor Frédérique Penault-Llorca: Unlocking the Oncotype DX Breast Recurrence Score^® Test: Unique design and development to bring clarity to treatment decisions

Professor Christos Sotiriou: Emerging Trends on Treatment Guidance in Early Breast Cancer: Unveiling clinical implications from latest updates from TAILORx and RxPONDER

Professor Marc A. Thill: Advancing Treatment Approaches and Neoadjuvant Therapy in Early Breast Cancer: Evidence-based strategies

Loading component...

19th St. Gallen International Breast Cancer Conference

Key Messages from the Exact Sciences Symposium

Professor Shani Paluch-Shimon: Optimizing systemic treatment choices using the Oncotype DX BreastRecurrence Score Result pre-operatively

Professor, Stephen Chia MD, FRCP(C): Directing Neoadjuvant Chemotherapy (NAC) using the Oncotype DXBreast Recurrence Score Result

Mr Henry Cain: Genomic testing on excision sample vs core biopsy: What we can learn from PreDX?

Patient perspectives: A round table discussion with Prof. Stephen Chia, Prof. Shani Paluch Shimon, and Mr Henry Cain

Loading component...

Previous events video library

ESMO 2024 Satellite symposium recording

[ESMO24] Insights from ESMO24 - Exact Sciences Educational Symposium

Tools to Guide Treatment Decisions in Early Breast Cancer: Genomic Testing and Emerging Role of MRD

[ESMO24] Evolving role of genomic assays in early breast cancer

Prof. Miguel Martin discusses the application of genomic assays in the neoadjuvant setting

[ESMO24] Tissue-based genomics to guide adjuvant therapy decisions

Prof. Janice Walshe discusses the impact of the introduction of genomic assays on clinical practice for both clinicians and patients.

[ESMO24] Introduction to MRD in breast cancer

Prof. Nicholas Turner provides a brief overview of the concept and terms related to molecular residual disease.

[ESMO24] Evolving role of MRD guided decision making in early breast cancer

Prof. Sherene Loi presented at ESMO 2024 an update on the current data and ongoing studies on molecular residual disease in early breast cancer.

[ESMO24] Optimizing the approach to MRD assay development

Rick Baehner provides a topline overview of ongoing research into the development of MRD assays.

EBCC 2024 Satellite symposium recording

[St Gallen BCC] Evolving clinical practice for multi-gene assays: what’s new!

Evolving clinical practice for multi-gene assays: what’s new!

[St Gallen BCC] Implications of updated guidelines for MGAs: Introduction

Implications of updated guidelines for MGAs: Introduction

[St Gallen BCC] Implementation of guidelines into clinical practice: expert discussion on challenging cases - Large tumour

Implementation of guidelines into clinical practice: expert discussion on challenging cases - Large tumour

[St Gallen BCC] Implementation of guidelines into clinical practice: expert discussion on challenging cases - Elderly patient

Professor Laura Biganzoli presented a challenging case study of an elderly patient with early breast cancer, focusing on the important interplay between genomic tools and patients’ characteristics.

[St Gallen BCC] Challenging cases: N1 – premenopausal

Professor Christian Kurzeder presented a challenging case study of a N1 premenopausal patient, focusing on how ODX and clinical evidence may help...

Loading component...

Listen Rick Baehner, MD and Helen Bailey, MD share insights of a centralized laboratory & give perspectives how expertise in genomic testing will...

Insights and perspectives from a centralized lab

Loading component...

Hear Prof. Giancarlo Pruneri of the University of Milan providing his insights on the importance of analytical work and the critical need to...

The pathologist's impact on clinical practice & patients' lives

Loading component...

Rick Baehner, MD - Exact Science’s Chief Medical Officer, presents on the analytical validation and the key clinical attributes of the the Oncotype...

The development of the ODX BRS test in breast cancer

Loading component...

Rick Baehner, MD - Exact Science’s Chief Medical Officer, presents on the clinical validation of the Oncotype DX^® test in TAILORx (N0 population)...

Clinical validation of the ODX BRS test in breast cancer

Loading component...

Rick Baehner, MD - Exact Science’s Chief Medical Officer, presents on the Oncotype DX^® test in ongoing trials.

Future of the ODX BRS test in breast cancer

Loading component...

Have questions about Oncotype DX^®?

Doctor sitting with patient having a discussion.